Advertisement
Advertisement
Addus HomeCare Corporation (ADUS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 99.71 |
| Open | 99.45 |
| Bid | 40.96 x 800 |
| Ask | 164.19 x 900 |
| Day's Range | 98.70 - 103.01 |
| 52 Week Range | 73.66 - 114.99 |
| Volume | |
| Avg. Volume | 90,673 |
| Market Cap | 1.659B |
| Beta (5Y Monthly) | 0.83 |
| PE Ratio (TTM) | 49.26 |
| EPS (TTM) | 2.09 |
| Earnings Date | May 01, 2023 - May 05, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 125.13 |
- Zacks
Is Addus HomeCare (ADUS) Stock Outpacing Its Medical Peers This Year?
Here is how Addus HomeCare (ADUS) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.
- Zacks
Zacks Industry Outlook Highlights Chemed, Addus HomeCare, RadNet and The Pennant Group
Chemed, Addus HomeCare, RadNet and The Pennant Group are part of the Zacks Industry Outlook article.
- Zacks
4 Promising Stocks From a Challenging Outpatient Home Health Industry
Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. CHE, ADUS, RDNT and PNTG are well poised to gain from the prospects.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
